Recruiting

Observational Study

Sponsor:

American Academy of Ophthalmology

Code:

NCT02485847

Conditions

Eye Diseases

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Ophthalmology

Study Details

Brief summary:

The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.

Conditions

Eye Diseases

Study ID

NCT02485847

Start date

Mar, 2014

Status verified date

Jul, 2016

Completion date

Jan, 2100

Anticipated

Primary completion date

Jan, 2100

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients who meet the denominator requirements for each measure.

Exclusion Criteria:

  • None

Study Design

Enrollment

20000000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Ophthalmology

A registry of ophthalmic ambulatory encounters which captures essential data elements for continuous quality improvement efforts, enhanced patient care outcomes, and pay for performance programs.

Primary outcome measure

  • Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation [ Time Frame: Up to 5 years ]
  • Age-Related Macular Degeneration (AMD): Dilated Macular Examination [ Time Frame: Up to 5 years ]
  • Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy [ Time Frame: Up to 5 years ]
  • Diabetic Retinopathy: Communication with the Physician Managing On-going Diabetes Care [ Time Frame: Up to 5 years ]
  • Preventive Care and Screening: Influenza Immunization [ Time Frame: Up to 5 years ]
  • Pneumonia Vaccination Status for Older Adults [ Time Frame: Up to 5 years ]
  • Diabetes Mellitus: Dilated Eye Exam in Diabetic Patient [ Time Frame: Up to 5 years ]
  • Documentation of Current Medications in the Medical Record [ Time Frame: Up to 5 years ]
  • Melanoma: Continuity of Care - Recall System [ Time Frame: Up to 5 years ]
  • Melanoma: Coordination of Care [ Time Frame: Up to 5 years ]
  • Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement [ Time Frame: Up to 5 years ]
  • Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% or Documentation of a Plan of Care [ Time Frame: Up to 5 years ]
  • Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery [ Time Frame: Up to 5 years ]
  • Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures [ Time Frame: Up to 5 years ]
  • Melanoma: Overutilization of Imaging Studies in Melanoma [ Time Frame: Up to 5 years ]
  • Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention [ Time Frame: Up to 5 years ]
  • Controlling High Blood Pressure [ Time Frame: Up to 5 years ]
  • Use of High-Risk Medications in the Elderly [ Time Frame: Up to 5 years ]
  • Biopsy Follow-Up [ Time Frame: Up to 5 years ]
  • Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery [ Time Frame: Up to 5 years ]
  • Patient Satisfaction within 90 Days Following Cataract Surgery [ Time Frame: Up to 5 years ]
  • Falls: Screening for Future Fall Risk [ Time Frame: Up to 5 years ]
  • Closing the Referral Loop: Receipt of Specialist Report [ Time Frame: Up to 5 years ]
  • Adult Primary Rhegmatogenous Retinal Detachment Repair Success Rate [ Time Frame: Up to 5 years ]
  • Adult Primary Rhegmatogenous Retinal Detachment Surgery Success Rate [ Time Frame: Up to 5 years ]
  • Cataract Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior Capsule requiring unplanned vitrectomy) [ Time Frame: Up to 5 years ]
  • Cataract Surgery: Difference Between Planned and Final Refraction [ Time Frame: Up to 5 years ]
  • Tobacco Use and Help with Quitting Among Adolescents [ Time Frame: Up to 5 years ]
  • Corneal Graft: 20/40 or Better Visual Acuity within 90 Days following Corneal Graft Surgery [ Time Frame: Up to 5 years ]
  • Open-Angle Glaucoma: Intraocular Pressure Reduction [ Time Frame: Up to 5 years ]
  • Open-Angle Glaucoma: Visual Field Progression [ Time Frame: Up to 5 years ]
  • Open-Angle Glaucoma: Intraocular Pressure Reduction Following Laser Trabeculoplasty [ Time Frame: Up to 5 years ]
  • Acquired Involutional Ptosis: Improvement of Marginal Reflex Distance within 90 Days Following Surgery for Acquired Involutional Ptosis [ Time Frame: Up to 5 years ]
  • Acquired Involutional Entropion: Normalization of Eyelid Position within 90 Days Following Surgery for Acquired Involutional Entropion [ Time Frame: Up to 5 years ]
  • Amblyopia: Improvement of Corrected Interocular Visual Acuity Difference to 2 or fewer Lines [ Time Frame: Up to 5 years ]
  • Surgical Esotropia: Patients with Postoperative Alignment of 15 prism diopters or less [ Time Frame: Up to 5 years ]
  • Diabetic Retinopathy: Dilated Eye Exam [ Time Frame: Up to 5 years ]
  • Exudative Age-Related Macular Degeneration: Loss of Visual Acuity [ Time Frame: Up to 5 years ]
  • Nonexudative Age-Related Macular Degeneration: Loss of Visual Acuity [ Time Frame: Up to 5 years ]
  • Diabetic Macular Edema: Loss of Visual Acuity [ Time Frame: Up to 5 years ]
  • Rhegmatogenous Retinal Detachment Surgery: Visual acuity improvement within 90 days of surgery [ Time Frame: Up to 5 years ]
  • Rhegmatogenous Retinal Detachment Surgery: Return to the operating room within 90 days of surgery [ Time Frame: Up to 5 years ]
  • Acute Anterior Uveitis: Post-treatment visual acuity [ Time Frame: Up to 5 years ]
  • Acute Anterior Uveitis: Post-treatment Grade 0 anterior chamber cells [ Time Frame: Up to 5 years ]
  • Chronic Anterior Uveitis: Post-treatment visual acuity [ Time Frame: Up to 5 years ]
  • Chronic Anterior Uveitis: Post-treatment Grade 0 anterior chamber cells [ Time Frame: Up to 5 years ]

Central Contacts and Locations

Locations

American Academy of Opthalmology

Recruiting

San Francisco, California, United States, 94109

Contacts

More Information

Sponsor

American Academy of Ophthalmology

Last update posted

Jul 12, 2016

Last verified

Jul, 2016

Keywords

  • Eye Diseases

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by American Academy of Ophthalmology on 2016-07-12.